Relative to focal segmental glomerulosclerosis.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 5 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

43.9% Uncertain

Why this number

Stage base Passed First Chamber — base rate 56%, measured from CA's completed sessions
Momentum +4 70/100 from the pace of recorded action
Time since last action -17 123 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.